SABA Reliever Over-Reliance
Many people with asthma tend to over-rely on their short-acting β2-agonist (SABA) inhaler [1,2]. Although SABAs provide quick relief of symptoms, overuse can increase the risk of exacerbations .
The Blue Reliever Reliance Test – featuring a simple, five-item, evidence-based questionnaire – can support you to assess SABA over-reliance with your patients and explore their asthma management needs.
Are your asthma patients over-reliant on their SABA inhalers?